BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18842997)

  • 1. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
    Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers.
    Pepe C; Guidugli L; Sensi E; Aretini P; D'Andrea E; Montagna M; Manoukian S; Ottini L; Radice P; Viel A; Bevilacqua G; Caligo MA
    Breast Cancer Res Treat; 2007 May; 103(1):29-36. PubMed ID: 17151928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women.
    Barbosa PR; Stabler SP; Machado AL; Braga RC; Hirata RD; Hirata MH; Sampaio-Neto LF; Allen RH; Guerra-Shinohara EM
    Eur J Clin Nutr; 2008 Aug; 62(8):1010-21. PubMed ID: 17522601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
    Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
    Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of MTHFR C677T and A1298C, and MTR A2756G gene polymorphisms in breast cancer risk in a population in Northeast Brazil.
    de Cássia Carvalho Barbosa R; da Costa DM; Cordeiro DE; Vieira AP; Rabenhorst SH
    Anticancer Res; 2012 Nov; 32(11):4805-11. PubMed ID: 23155246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma.
    Matsuo K; Hamajima N; Suzuki R; Ogura M; Kagami Y; Taji H; Yasue T; Mueller NE; Nakamura S; Seto M; Morishima Y; Tajima K
    Am J Hematol; 2004 Dec; 77(4):351-7. PubMed ID: 15551285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk.
    Suzuki T; Matsuo K; Sawaki A; Mizuno N; Hiraki A; Kawase T; Watanabe M; Nakamura T; Yamao K; Tajima K; Tanaka H
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2742-7. PubMed ID: 18843018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
    Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population.
    Ouerhani S; Oliveira E; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; El Gaaied AB; Prata MJ
    Cancer Genet Cytogenet; 2007 Jul; 176(1):48-53. PubMed ID: 17574963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk.
    Lima CS; Ortega MM; Ozelo MC; Araujo RC; De Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; Costa FF
    Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the relations between genetic polymorphisms in methylenetetrahydrofolate reductase, methionine synthase and the risk of pancreatic cancer].
    Wang L; Lin DX; Lu XH; Miao XP; Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Jan; 27(1):50-4. PubMed ID: 16737574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany.
    Justenhoven C; Hamann U; Pierl CB; Rabstein S; Pesch B; Harth V; Baisch C; Vollmert C; Illig T; Brüning T; Ko Y; Brauch H
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):3015-8. PubMed ID: 16365030
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency.
    Beetstra S; Salisbury C; Turner J; Altree M; McKinnon R; Suthers G; Fenech M
    Carcinogenesis; 2006 Mar; 27(3):517-24. PubMed ID: 16162645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in folate-related enzyme genes in idiopathic infertile Brazilian men.
    Gava MM; Kayaki EA; Bianco B; Teles JS; Christofolini DM; Pompeo AC; Glina S; Barbosa CP
    Reprod Sci; 2011 Dec; 18(12):1267-72. PubMed ID: 21775772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma.
    Bethke L; Webb E; Murray A; Schoemaker M; Feychting M; Lönn S; Ahlbom A; Malmer B; Henriksson R; Auvinen A; Kiuru A; Salminen T; Johansen C; Christensen HC; Muir K; McKinney P; Hepworth S; Dimitropoulou P; Lophatananon A; Swerdlow A; Houlston R
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1195-202. PubMed ID: 18483342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians.
    Vinukonda G; Shaik Mohammad N; Md Nurul Jain J; Prasad Chintakindi K; Rama Devi Akella R
    Clin Chim Acta; 2009 Jul; 405(1-2):127-31. PubMed ID: 19394322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
    King TA; Li W; Brogi E; Yee CJ; Gemignani ML; Olvera N; Levine DA; Norton L; Robson ME; Offit K; Borgen PI; Boyd J
    Ann Surg Oncol; 2007 Sep; 14(9):2510-8. PubMed ID: 17597348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms predisposing to hyperhomocysteinemia in cardiac transplant patients.
    Miriuka SG; Langman LJ; Evrovski J; Miner SE; D'Mello N; Delgado DH; Wong BY; Ross HJ; Cole DE
    Transpl Int; 2005 Jan; 18(1):29-35. PubMed ID: 15612980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.
    Hughes DJ; Ginolhac SM; Coupier I; Corbex M; Bressac-de-Paillerets B; Chompret A; Bignon YJ; Uhrhammer N; Lasset C; Giraud S; Hardouin A; Berthet P; Peyrat JP; Fournier J; Nogues C; Lidereau R; Muller D; Fricker JP; Longy M; Toulas C; Guimbaud R; Maugard C; Olschwang S; Yannoukakos D; Durocher F; Moisan AM; Simard J; Mazoyer S; Lynch HT; Szabo C; Lenoir GM; Goldgar DE; Stoppa-Lyonnet D; Sinilnikova OM
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):265-7. PubMed ID: 15668505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.